Auflistung nach Institut Institut für Zellbiologie und Immunologie

Gehe zu: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
oder geben Sie die Anfangszeichen ein:  
Anzeige der Treffer 77 bis 96 von 135 < zurück   nächste
ErscheinungsdatumTitelAutor(en)
2011Modeling time delay in the NF&#954;B signaling pathway following low dose IL-1 stimulationWitt, Johannes; Barisic, Sandra; Sawodny, Oliver; Ederer, Michael; Kulms, Dagmar; Sauter, Thomas
2002Molekulare Mechanismen der Antiöstrogenwirkung beim MammakarzinomBuck, Miriam
2002Molekulare Mechanismen der pro-apoptotischen Kooperation zwischen TNF-R1 und Nicht-Todesrezeptoren der TNF-RezeptorfamilieFotin-Mleczek, Mariola
2002Molekulare Mechanismen der Tumor-Nekrose-Faktor-Rezeptor-1 (TNF-R1)-vermittelten ApoptoseWeingärtner, Monika
2021Multiphasic modelling and computation of metastatic lung-cancer cell proliferation and atrophy in brain tissue based on experimental dataEhlers, Wolfgang; Rehm, Markus; Schröder, Patrick; Stöhr, Daniela; Wagner, Arndt
2017Multivalent antibody-scTRAIL fusion proteins for tumor therapy : impact of format and targetingHutt, Meike
2001Der murine Chemokinrezeptor CCR2 : Herstellung von Null-Mutanten durch homologe Rekombination in embryonalen StammzellenMaier, Holger
2000Neuartige retrovirale Vektorsysteme für die Gentherapie: Entwicklung in Suspension wachsender VerpackungszellinienGutjahr, Thorsten S.
2008Neue TRAIL-Varianten für die zielgerichtete TumortherapieSchneider, Britta
2018Novel EGFR family member binding antibodies as cancer therapeuticsSchmitt, Lisa
2009Novel electrokinetic approaches to improve purification processes with monoclonal antibodiesFaude, Alexander
2022Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatmentHeine, Simon
2022Overcoming glioblastoma intractability : pre-clinical characterisation of TRAIL sensitisation by marizomib and novel treatment perspectivesBoccellato, Chiara
2021Pharmacokinetic engineering of OX40-blocking anticalin proteins using monomeric plasma half-life extension domainsSiegemund, Martin; Oak, Prajakta; Hansbauer, Eva-Maria; Allersdorfer, Andrea; Utschick, Karoline; Winter, Alexandra; Grasmüller, Christina; Galler, Gunther; Mayer, Jan-Peter; Weiche, Benjamin; Prassler, Josef; Kontermann, Roland E.; Rothe, Christine
2010Phenocopy : a strategy to qualify chemical compounds during hit-to-lead and/or lead optimizationBaum, Patrick
2014Population and single-cell based quantitative analysis of protein kinase D-mediated regulation of the cell cycleRäth, Sebastian
2020Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical modelTsur, Neta
2023Prognostication and prediction of cancer patient outcomes using AI-based classifiersGuttà, Cristiano
2021Proteasome inhibition triggers the formation of TRAIL receptor 2 platforms for caspase-8 activation that accumulate in the cytosolHellwig, Christian T.; Delgado, M. Eugenia; Skoko, Josip; Dyck, Lydia; Hanna, Carol; Wentges, Alexa; Langlais, Claudia; Hagenlocher, Cathrin; Mack, Alexandra; Dinsdale, David; Cain, Kelvin; MacFarlane, Marion; Rehm, Markus
2008Protein kinase D (PKD) mouse models – towards an understanding of the physiological role of PKDEllwanger, Kornelia